- Home
- LSTA vs ANEB Comparison
LSTA vs ANEB Comparison
Compare LSTA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- ANEB
- Stock Information
- Founded
- LSTA 1980
- ANEB 2020
- Country
- LSTA United States
- ANEB United States
- Employees
- LSTA N/A
- ANEB N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- ANEB Health Care
- Exchange
- LSTA Nasdaq
- ANEB Nasdaq
- Market Cap
- LSTA 20.0M
- ANEB 36.7M
- IPO Year
- LSTA N/A
- ANEB 2021
- Fundamental
- Price
- LSTA $2.21
- ANEB $1.64
- Analyst Decision
- LSTA Strong Buy
- ANEB Buy
- Analyst Count
- LSTA 1
- ANEB 1
- Target Price
- LSTA $15.00
- ANEB $8.00
- AVG Volume (30 Days)
- LSTA 17.1K
- ANEB 24.3K
- Earning Date
- LSTA 02-27-2025
- ANEB 02-14-2025
- Dividend Yield
- LSTA N/A
- ANEB N/A
- EPS Growth
- LSTA N/A
- ANEB N/A
- EPS
- LSTA N/A
- ANEB N/A
- Revenue
- LSTA $1,000,000.00
- ANEB N/A
- Revenue This Year
- LSTA N/A
- ANEB N/A
- Revenue Next Year
- LSTA N/A
- ANEB N/A
- P/E Ratio
- LSTA N/A
- ANEB N/A
- Revenue Growth
- LSTA N/A
- ANEB N/A
- 52 Week Low
- LSTA $2.05
- ANEB $0.80
- 52 Week High
- LSTA $4.20
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- LSTA 38.28
- ANEB 56.08
- Support Level
- LSTA $2.05
- ANEB $0.91
- Resistance Level
- LSTA $2.46
- ANEB $1.20
- Average True Range (ATR)
- LSTA 0.20
- ANEB 0.17
- MACD
- LSTA 0.01
- ANEB 0.01
- Stochastic Oscillator
- LSTA 32.81
- ANEB 60.86
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.